Trials / Completed
CompletedNCT02299687
Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole
A Clinical Trial to Investigate the Influence of CYP2C19 Polymorphism on Pharmacokinetic/Pharmacodynamic Characteristics of Omeprazole in Healthy Korean Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A clinical trial to investigate the influence of CYP2C19 polymorphism on pharmacokinetic/pharmacodynamic characteristics of omeprazole in healthy Korean volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omeprazole |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2014-12-01
- First posted
- 2014-11-24
- Last updated
- 2015-01-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02299687. Inclusion in this directory is not an endorsement.